64Cu-FBP8 PET-CT Imaging for Blood Clots
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a new imaging tool that helps doctors see fresh blood clots in patients with PE and DVT. It uses a special substance that binds to the clots, making them visible on a PET scan. This could improve diagnosis, especially for patients with kidney or lung problems.
Who Is on the Research Team?
Tilo Winkler, PhD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a recent diagnosis of pulmonary embolism or deep vein thrombosis confirmed by CT scans. Participants must be able to lie flat for 45 minutes and have adequate kidney function. Pregnant women, those exceeding weight limits for PET imaging, or individuals exposed to high levels of radiation in the past year are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 64Cu-FBP8 and undergo PET-CT imaging to assess thrombus location and clot burden
Follow-up
Participants are monitored for safety and effectiveness after imaging
What Are the Treatments Tested in This Trial?
Interventions
- 64Cu-FBP8
- PET-CT Imaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Peter David Caravan
Lead Sponsor
Peter Caravan
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator